Non-tumorous feminizing adrenogenital syndrome in the male subject.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis / Q000473:pathology; D000308:Adrenocortical Hyperfunction / Q000150:complications* / Q000175:diagnosis / Q000473:pathology; D000735:Androstenedione / Q000097:blood; D000738:Androsterone / Q000097:blood; D004967:Estrogens / Q000652:urine; D005262:Feminization / Q000209:etiology*; D006177:Gynecomastia / Q000209:etiology*; D006801:Humans; D006854:Hydrocortisone / Q000652:urine; D008297:Male; D010912:Pituitary-Adrenal Function Tests; D011279:Pregnanetriol / Q000652:urine; D012728:Sex Chromatin; D013091:Spermatogenesis; D013737:Testis / Q000473:pathology; D013739:Testosterone / Q000097:blood / Q000652:urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D004967:Estrogens; D011279:Pregnanetriol; D013739:Testosterone; D000735:Androstenedione; D000738:Androsterone; D006854:Hydrocortisone